DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Oprelvekin
Oprelvekin
THE CONCISE GUIDE to PHARMACOLOGY 2017/18 Alexander, Stephen P
Quantum of Effectiveness Evidence in FDA's Approval of Orphan Drugs
NMMC West Point CDM.Xlsx
Monitoring and Mathematical Modeling of in Vitro Human Megakaryocyte Expansion and Maturation Dynamics
CDER List of Licensed Biological Products With
Evaluating the Effect of Oprelvekin on Cardiac Repolarization in Subjects with Chemotherapy-Induced Thrombocytopenia: an Observa
Standard Specialty PA and QL List January 2015
Pharmacology of Recombinant Or Genetically Engineered Drugs
Specialty Pharmacy Drug List
Medications Requiring Prior Authorization
Biopharmaceutical Benchmarks 2018
INN Working Document 05.179 Update December 2010
Policy&Procedure Um Onc 1213
Oprelvekin (Neumega) Reference Number: CP.CPA.128 Effective Date: 11.16 Last Review Date: 11.17 Revision Log Line of Business: Commercial
Catalytic Receptors', British Journal of Pharmacology, Vol
Colorado 4Th Tier Medication List
Ncounter® Host Response Panel - Gene and Probe Details
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Top View
CDER List of Licensed Biological Products With
Authorization Requirements for Medications Under the Medical Benefit
Interleukin 11 (IL-11): Role(S) in Breast Cancer Bone Metastases
Oprelvekin (Other Names: Neumega®) | UPMC Hillman Cancer Center
Neumega
1 Update #12 ALLIANCE for CLINICAL TRIALS IN
Graft-Versus-Host Disease a Phase I/II Double-Blind, Placebo-Controlled
Molecular Engineering of Therapeutic Cytokines
ATTENTION: Allwell from Absolute Total Care Medicare Prior Authorization Updates
NEUMEGA® (Oprelvekin)
IL11 As a Tumor-Promoting Cytokine—Translational Implications for Cancers
BQC19 Core Analyses Table of Contents
Appendix B. Drug Codes Requiring Authorization the Following Codes Will Require Authorization for MA Effective Oct 1, 2017 Page
Immune-Modulators to Combat Hepatitis B Virus Infection: From
Quarterly Review
Oprelvekin, (Neumega) Genetics Institute, Inc
Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
Catalytic Receptors